Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
8.82
+0.30 (3.52%)
Apr 1, 2025, 2:45 PM CST
SHE:300009 Revenue
In the year 2024, Anhui Anke Biotechnology (Group) had annual revenue of 2.54B CNY, down -11.51%. Anhui Anke Biotechnology (Group) had revenue of 614.76M in the quarter ending December 31, 2024, a decrease of -27.19%.
Revenue
2.54B
Revenue Growth
-11.51%
P/S Ratio
5.62
Revenue / Employee
958.08K
Employees
2,647
Market Cap
14.21B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.54B | -329.71M | -11.51% |
Dec 31, 2023 | 2.87B | 534.69M | 22.94% |
Jan 1, 2023 | 2.33B | 162.30M | 7.48% |
Dec 31, 2021 | 2.17B | 467.35M | 27.47% |
Dec 31, 2020 | 1.70B | -11.11M | -0.65% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 26.00B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |